Ozempic

Israel McKenzie says the weight-loss drug Wegovy helped him shed 110 pounds in nine months, making him part of what new research shows is a sharp surge in the ...

A survey from KFF found most Americans believe Ozempic, Wegovy, and other GLP-1 drugs should be covered by Medicare for weight loss.

Roughly 15.5 million Americans have tried Ozempic or similar drugs, according to a new poll by Gallup.

A report by researchers at the University of Michigan and Yale revealed monthly scripts for GLP-1 drugs, which also included Wegovy, shot up from 8700 in ...

The use of weight-loss drugs such as Wegovy and Ozempic has climbed among children in the United States, according to a study released Wednesday.

Why it matters: For now, drugmakers are largely getting a pass from the public on the high prices of these transformational treatments, even as inflation-weary ...

Novo Nordisk, maker of the blockbuster drugs for diabetes and weight loss respectively, has a market capitalisation of $592.02 billion, making it larger ...

For many people on Ozempic and other GLP-1 drugs (medications that treat Type 2 diabetes and obesity), one of the biggest struggles is deciding what they ...

Chef Andrew Zimmern shares his thoughts on new Ozempic-friendly meals as a new line of prepared foods is set to hit stores.

It's not the first brand to pivot in the new era of weight-loss drugs.

Nestlé, the maker of frozen food brands like Stouffer's and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs, ...

Our quickfire analysis of the brand, marketing and media stories that might just crop up in your meetings and conversations today.

Nestlé has a new line, Vital Pursuit, for Ozempic and other GLP-1 users.

Even as millions of older adults clamor for drugs such as Ozempic and Wegovy, monthly use of the medications soared in people aged 12 to 25.

More than 60000 teens and young adults are being prescribed Ozempic and similar medications monthly, as experts point to increasing rates of childhood ...

As humble jesters of the court of late-stage capitalism, we're not really qualified to address the far-reaching ramifications of weight-loss drugs like ...

British chef Nigella Lawson says someone commented that Ozempic made them not think about food all the time, leading her to admit that she 'can't imagine ...

Nestlé, the maker of frozen food brands like Stouffer's and DiGiorno, is slimming down with a new line of meals for people taking GLP-1 drugs, ...

The company behind those viral ED ads is releasing its own version of Ozempic — but its means of acquiring the drug might not be the safest.

Telehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to Ozempic and Wegovy at a significantly lower price.

The $278 million company has added a weight-loss drug to its mix of bargain health care treatments.

Novo Nordisk Oceania managing director Cem Ozenc mourns the fact Australia's obesity challenge is lost amid the celebrity hype surrounding the medication.

Telehealth provider Hims & Hers recently announced it will start selling compound versions of the popular diabetes and weight loss drugs Ozempic and Wegovy.

The price of prescription compounded semaglutide will start at $199 per month — directly competing with costlier Ozempic and Wegovy.

A year after revealing she quit using drug Ozempic to lose weight, TikToker star Remi Bader shared before-and-after videos of her fitness journey, ...

The market for GLP-1 drugs used to be rather concentrated among two key players, but that's changing. Him & Hers (HIMS) and Mangoceuticals (MGRX) have come ...